港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科濟藥業-B

15.940

+0.4002.57%

成交量：100.05萬

成交額：1,586.22萬

市值：91.34億

市盈率：-10.27

高：16.000

開：15.500

低：15.400

收：15.540

資料載入中...

總覽公司新聞公告

港股異動 | 科濟藥業-B(02171)漲近7% Claudin18.2 CAR-T納入突破性治療藥物品種有望上半年申請上市

科濟藥業-B盤中異動下午盤急速上漲5.00%報15.960港元

華東醫藥：公司與科濟藥業合作進行商業化的賽愷澤產品目前市場拓展順利

CAR-T的“資本寒冰”開始融化

Ofweek维科网

科濟藥業獲珠海軟銀戰略投資 CAR-T賽道迎來破冰信號

科濟藥業-B盤中異動早盤股價大跌5.08%

科濟藥業-B03月04日遭主力拋售211萬元

港股異動 | 科濟藥業-B(02171)漲超6% Claudin18.2 CAR-T舒瑞基奧侖賽注射液納入突破性治療藥物品種

科濟藥業-B(02171)上漲5.26%，報16.8元/股

科濟藥業-B盤中異動早盤股價大漲5.01%報16.760港元

科濟藥業Claudin18.2 CAR-T舒瑞基奧侖賽注射液納入突破性治療藥物品種

多家港股創新藥企開年股價翻倍

全球首款實體瘤CAR-T細胞產品突破性療法獲批在即，科濟藥業（02171）率先破局

科濟藥業-B盤中異動股價大跌5.01%報15.920港元

科濟藥業通用型CD19/CD20 CAR-T產品完成首例自身免疫性疾病受試者給藥

科濟藥業引資8000萬，加速CAR-T產品國內進程！

生物药大时代

珠海軟銀欣創投資8000萬元增資優愷澤，科濟藥業權益稀釋至92%

科濟藥業-B盤中異動快速拉昇5.12%報17.660港元

科濟藥業(02171.HK)附屬優愷澤獲基金增資8,000萬人民幣

阿斯达克财经

科濟藥業-B(02171)引入珠海軟銀欣創投資以加速通用型CAR-T細胞產品在中國內地進程

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02171/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02171","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02171\",,,,,undefined,":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科濟藥業-B","latestPrice":15.94,"timestamp":1746173305030,"preClose":15.54,"halted":0,"volume":1000500,"delay":0,"floatShares":573000000,"shares":573000000,"eps":-1.5514425331855661,"marketStatus":"休市中","change":0.4,"latestTime":"05-02 16:08:25","open":15.5,"high":16,"low":15.4,"amount":15862220,"amplitude":0.03861,"askPrice":15.94,"askSize":180000,"bidPrice":15.92,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.5514425331855661,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":7,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.54,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.5631543397120463,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02171\",,,,,undefined,":{"symbol":"02171","floatShares":573000000,"roa":"-23.91%","roe":"-55.84%","lyrEps":-1.551443,"volumeRatio":0.5631543397120463,"shares":573000000,"dividePrice":0,"high":16,"amplitude":0.03861,"preClose":15.54,"low":15.4,"week52Low":2.48,"pbRate":"8.04","psRate":"215.57","week52High":19.78,"institutionHeld":0,"latestPrice":15.94,"committee":-0.967213,"eps":-1.5514425331855661,"divideRate":0,"volume":1000500,"delay":0,"ttmEps":-1.5514425331855661,"open":15.5,"prevYearClose":9.21,"prevWeekClose":15.4,"prevMonthClose":15.54,"prevQuarterClose":15.46,"fiveDayClose":15.7,"twentyDayClose":15.46,"sixtyDayClose":10.2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02171\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517189469","title":"港股異動 | 科濟藥業-B(02171)漲近7% Claudin18.2 CAR-T納入突破性治療藥物品種 有望上半年申請上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2517189469","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517189469?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:14","pubTimestamp":1741245299,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B涨近7%，截至发稿，涨4.74%，报15.92港元，成交额1.01亿港元。消息面上，科济药业近日宣布，公司自主研发的舒瑞基奥仑赛注射液已被国家药品监督管理局药品审评中心纳入突破性治疗药物品种名单，拟定适应症为既往接受过至少二线治疗失败的Claudin18.2表达阳性的晚期胃/食管胃结合部腺癌。公司预计将于2025年上半年向国家药品监督管理局递交舒瑞基奥仑赛注射液的新药上市申请。此次增资完成后，公司的权益将由100%稀释至92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1585","CAR","BK4230","BK1161","02171","BK1574","BK4022"],"gpt_icon":0},{"id":"2517318854","title":"科濟藥業-B盤中異動 下午盤急速上漲5.00%報15.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517318854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517318854?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:11","pubTimestamp":1741237872,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘13时11分，科济药业-B股票出现异动，股价快速拉升5.00%。截至发稿，该股报15.960港元/股，成交量434.15万股，换手率0.76%，振幅5.00%。科济药业-B股票所在的生物技术行业中，整体涨幅为0.35%。2月26日，科济药业公告披露，旗下优恺泽生物完成珠海软银主导的8000万元战略融资，对应估值达10亿元。科济药业的转型之路颇具行业启示意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306131112963baef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306131112963baef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1574","BK1161","BK1587","02171"],"gpt_icon":0},{"id":"2517188360","title":"華東醫藥：公司與科濟藥業合作進行商業化的賽愷澤 產品目前市場拓展順利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517188360","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517188360?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:04","pubTimestamp":1741237440,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n　　证券之星消息，华东医药(000963)03月05日在投资者关系平台上答复投资者关心的问题。　　投资者：贵公司今后还有没有和科济药业继续合作的项目？　　华东医药董秘：您好！公司与科济药业合作进行商业化的赛恺泽产品目前市场拓展顺利。今后公司如有进一步的对外合作计划，将按照信息披露相关规定及时公告。感谢您的关注！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenswir0946806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK0183","BK0196","BK0209","000963","BK1585","BK1587","BK0175","LU1969619763.USD","BK0187","LU2328871848.SGD","BK0132","BK0188","BK1574","02171"],"gpt_icon":0},{"id":"2517960367","title":"CAR-T的“資本寒冰”開始融化","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960367","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517960367?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 16:22","pubTimestamp":1741162931,"startTime":"0","endTime":"0","summary":"在市场情绪最低落的时候，事情却悄然发生转机，艺妙神州、科济药业纷纷在近期宣布完成CAR-T融资协议，禁锢CAR-T产业的“寒冰”正在开始融化。这一融资金额虽然并不够，但考虑到通用型CAR-T依然处于临床早期阶段，表明资本已经开始将通用型CAR-T纳入估值体系。国内特殊的支付环境是CAR-T发展的最大障碍。科济药业与珠海软银的此次合作，或将成为CAR-T“资本寒冰”溶解的标志性事件。此外，CAR-T治疗实体瘤失败的案例更是频发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162228963a6e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162228963a6e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0},{"id":"2517969386","title":"科濟藥業獲珠海軟銀戰略投資 CAR-T賽道迎來破冰信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2517969386","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517969386?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 15:22","pubTimestamp":1741159320,"startTime":"0","endTime":"0","summary":"曾被资本狂热追捧的CAR-T疗法，在经历数年沉寂后近期再现融资暖流。科济药业与珠海软银日前达成的战略投资协议，引发市场对CGT赛道的重新审视。这不仅刷新了业界对通用型技术的认知，更预示着成本下降路径的可行性，据测算，异体CAR-T有望将生产成本从传统模式的近10万美元压缩至不足5000美元。2024年医保谈判中，CAR-T产品再次集体缺席，政策导向未现松动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305152311a2602df9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305152311a2602df9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1574","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"2517956905","title":"科濟藥業-B盤中異動 早盤股價大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517956905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517956905?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 11:11","pubTimestamp":1741144271,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘11时11分，科济药业-B股票出现异动，股价大幅下跌5.08%。截至发稿，该股报14.940港元/股，成交量458.65万股，换手率0.80%，振幅6.61%。科济药业-B股票所在的生物技术行业中，整体涨幅为0.97%。科济药业-B公司简介：科济药业控股有限公司是一家主要从事创新嵌合抗原受体T 细胞疗法发现、开发及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305111112abe8ce8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305111112abe8ce8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"2516251006","title":"科濟藥業-B03月04日遭主力拋售211萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516251006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516251006?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 17:38","pubTimestamp":1741081089,"startTime":"0","endTime":"0","summary":"03月04日, 科济药业-B股价跌0.88%，报收15.74元，成交金额9990万元，换手率1.10%，振幅5.92%，量比0.39。科济药业-B今日主力资金净流出211万元，上一交易日主力净流出335万元。该股近5个交易日上涨14.02%，主力资金累计净流入4243万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.05亿元，其中净流入天数为12日。该股主力净额占比0.02%，港股市场排名2489/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174110abe79212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174110abe79212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1585","02171","BK1587","BK1161"],"gpt_icon":0},{"id":"2516872522","title":"港股異動 | 科濟藥業-B(02171)漲超6% Claudin18.2 CAR-T舒瑞基奧侖賽注射液納入突破性治療藥物品種","url":"https://stock-news.laohu8.com/highlight/detail?id=2516872522","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516872522?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 09:48","pubTimestamp":1740966496,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B涨超6%，截至发稿，涨6.14%，报16.94港元，成交额5500.42万港元。消息面上，科济药业今早宣布，公司自主研发的舒瑞基奥仑赛注射液已被国家药品监督管理局药品审评中心纳入突破性治疗药物品种名单，拟定适应症为既往接受过至少二线治疗失败的Claudin18.2表达阳性的晚期胃/食管胃结合部腺癌。公司预计将于2025年上半年向国家药品监督管理局递交舒瑞基奥仑赛注射液的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4022","BK1585","02171","CAR","BK1587","BK1574","BK4230","BK1161"],"gpt_icon":0},{"id":"2516156524","title":"科濟藥業-B(02171)上漲5.26%，報16.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516156524","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516156524?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 09:40","pubTimestamp":1740966056,"startTime":"0","endTime":"0","summary":"3月3日，科济药业-B盘中上涨5.26%，截至09:40，报16.8元/股，成交4458.21万元。科济药业控股有限公司是一家专注于开发创新嵌合抗原受体T细胞疗法，治疗实体瘤和血液恶性肿瘤的生物制药公司。截至2024年中报，科济药业-B营业总收入634.0万元、净利润-3.52亿元。3月18日，科济药业-B将披露2024财年年报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/03094048477493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1587","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"2516524210","title":"科濟藥業-B盤中異動 早盤股價大漲5.01%報16.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516524210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516524210?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 09:30","pubTimestamp":1740965433,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时30分，科济药业-B股票出现波动，股价大幅上涨5.01%。截至发稿，该股报16.760港元/股，成交量143.35万股，换手率0.25%，振幅1.88%。资金方面，该股资金流入55.816万港元，流出216.311万港元。科济药业-B股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，永泰生物-B、科济药业-B、再鼎医药涨幅较大，振幅较大的相关个股有永泰生物-B、乐普生物-B、来凯医药-B，振幅分别为6.79%、4.11%、2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309303398992613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309303398992613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"2516357538","title":"科濟藥業Claudin18.2 CAR-T舒瑞基奧侖賽注射液納入突破性治療藥物品種","url":"https://stock-news.laohu8.com/highlight/detail?id=2516357538","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516357538?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 08:15","pubTimestamp":1740960900,"startTime":"0","endTime":"0","summary":"公司预计将于2025年上半年向国家药品监督管理局递交舒瑞基奥仑赛注射液的新药上市申请。\" 关于舒瑞基奥仑赛注射液 舒瑞基奥仑赛注射液是一种潜在全球同类首创的、靶向Claudin18.2蛋白的自体CAR-T细胞候选产品，用于治疗Claudin18.2阳性实体瘤，主要治疗胃癌/食管胃结合部腺癌及胰腺癌。2020年9月，舒瑞基奥仑赛注射液被美国FDA授予\"孤儿药\"认定用于治疗胃癌/食管胃结合部腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4630020_ZH30020_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["CAR","BK4230","BK1161","BK1585","02171","BK4022","BK1587","BK1574"],"gpt_icon":0},{"id":"2516939315","title":"多家港股創新藥企開年股價翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2516939315","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516939315?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 10:18","pubTimestamp":1740881939,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","HSTECH","159992","BK1587","02171","BK1583","BK1585","YANG","HSCEI","159718","06978","07226","BK1574","02142"],"gpt_icon":0},{"id":"2514244392","title":"全球首款實體瘤CAR-T細胞產品突破性療法獲批在即，科濟藥業（02171）率先破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2514244392","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514244392?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 14:21","pubTimestamp":1740723706,"startTime":"0","endTime":"0","summary":"2月28日，根据中国国家药品监督管理局官网显示，本日为全球首款实体瘤CAR-T细胞产品科济药业舒瑞基奥仑赛注射液突破性治疗药物认定程序公示期最后一日，获批在即。若最终获批，不仅在于其针对特定肿瘤标志物的精准打击能力，更在于它代表了CAR-T疗法在实体瘤治疗领域的一次重大飞跃。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK4022","BK4230","BK1587","BK1161","CAR","02171","BK1574"],"gpt_icon":0},{"id":"2514033369","title":"科濟藥業-B盤中異動 股價大跌5.01%報15.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514033369?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:55","pubTimestamp":1740707738,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时55分，科济药业-B股票出现波动，股价大幅跳水5.01%。截至发稿，该股报15.920港元/股，成交量190.3万股，换手率0.33%，振幅8.11%。资金方面，该股资金流入967.676万港元，流出1723.14万港元。科济药业-B股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，百济神州、正大企业国际、方达控股涨幅较大，振幅较大的相关个股有科笛-B、腾盛博药-B、宜明昂科-B，振幅分别为14.48%、12.44%、12.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095538a2571c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095538a2571c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1585","02171","BK1587","BK1574"],"gpt_icon":0},{"id":"2514036968","title":"科濟藥業通用型CD19/CD20 CAR-T產品完成首例自身免疫性疾病受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2514036968","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514036968?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 08:15","pubTimestamp":1740701700,"startTime":"0","endTime":"0","summary":"上海2025年2月28日 /美通社/ --科济药业，一家主要专注于治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法公司宣布，公司自主研发的一款靶向CD19/CD20的通用型CAR-T细胞治疗候选产品KJ-C2219，已在研究者发起的临床试验中完成首例以临床方案中起始剂量输注的系统性红斑狼疮受试者给药。在此平台下的通用型BCMA或CD19/CD20双靶CAR-T在NK存在时都显示出极强的抗肿瘤疗效，表明该平台可广泛用于多种通用型CAR-T细胞的研制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4628983_ZH28983_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4022","BK1574","CAR","BK1161","BK1585","BK4230","BK1587","02171"],"gpt_icon":0},{"id":"2514503623","title":"科濟藥業引資8000萬，加速CAR-T產品國內進程！","url":"https://stock-news.laohu8.com/highlight/detail?id=2514503623","media":"生物药大时代","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514503623?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 07:32","pubTimestamp":1740699123,"startTime":"0","endTime":"0","summary":"2月26日，科济药业发布公告，公司及若干附属公司与珠海横琴软银欣创股权投资管理企业旗下管理的基金达成协议。本次增资完成后，科济药业于优恺泽的权益将由100% 稀释至92%。优恺泽是一家在中国内地专注于利用通用型CAR-T细胞疗法治疗血液瘤的新药研发公司。根据协议，优恺泽获得科济药业治疗多发性骨髓瘤、浆细胞白血病的通用型BCMA CAR-T细胞产品以及治疗B细胞肿瘤的通用型CD19/CD20 CAR-T 细胞产品在中国内地的研发、生产与商业化的独家权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228080614a256fab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228080614a256fab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1585","02171","BK1574","BK1161"],"gpt_icon":0},{"id":"2514981456","title":"珠海軟銀欣創投資8000萬元增資優愷澤，科濟藥業權益稀釋至92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514981456","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514981456?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 10:07","pubTimestamp":1740622067,"startTime":"0","endTime":"0","summary":"2月27日，科济药业-B（02171）发布公告，宣布与珠海软银欣创达成协议，投资者将以现金对价8000万元认购优恺泽生物医药（上海）有限公司的新增注册资本，约占优恺泽增资后注册资本的8%。此次增资完成后，公司的权益将由100%稀释至92%。优恺泽专注于利用通用型CAR-T细胞疗法治疗血液瘤，获得了相关产品在中国内地的研发、生产与商业化的独家权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331295186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1585","BK1161","02171","BK1574","BK1587"],"gpt_icon":0},{"id":"2514819464","title":"科濟藥業-B盤中異動 快速拉昇5.12%報17.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514819464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514819464?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 09:37","pubTimestamp":1740620266,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时37分，科济药业-B股票出现波动，股价快速拉升5.12%。截至发稿，该股报17.660港元/股，成交量133.95万股，换手率0.23%，振幅5.71%。资金方面，该股资金流入1003.3万港元，流出1029.35万港元。科济药业-B股票所在的生物技术行业中，整体跌幅为0.98%。其相关个股中，创胜集团-B、永泰生物-B、北海康成-B涨幅较大，振幅较大的相关个股有永泰生物-B、创胜集团-B、科笛-B，振幅分别为15.11%、13.74%、9.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227093746a2558e28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227093746a2558e28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","02171","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2514850225","title":"科濟藥業(02171.HK)附屬優愷澤獲基金增資8,000萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850225","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514850225?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 00:44","pubTimestamp":1740588240,"startTime":"0","endTime":"0","summary":"科济药业－Ｂ(02171.HK) 公布，珠海软银欣创旗下管理的基金(投资者)以现金对价8,000万人民币认购优恺泽增资后注册资本8%。完成后，公司于优恺泽权益将由100%降至92%，后者是一家在内地专注于利用通用型CAR-T细胞疗法治疗血液瘤的新药研发公司。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-26 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211223145801127_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211223145801127_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1420512/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02171","BK1574","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"2514858403","title":"科濟藥業-B(02171)引入珠海軟銀欣創投資以加速通用型CAR-T細胞產品在中國內地進程","url":"https://stock-news.laohu8.com/highlight/detail?id=2514858403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514858403?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 21:56","pubTimestamp":1740578188,"startTime":"0","endTime":"0","summary":"本次增资完成后，本公司于优恺泽的权益将由100% 稀释至92%。优恺泽是一家在中国内地专注于利用通用型CAR-T细胞疗法治疗血液瘤的新药研发公司。根据该等协议，优恺泽获得本公司治疗多发性骨髓瘤、浆细胞白血病的通用型BCMA CAR-T细胞产品以及治疗B细胞肿瘤的通用型CD19/CD20 CAR-T 细胞产品在中国内地的研发、生产与商业化的独家权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK4230","BK1574","BK4022","BK1587","BK1161","02171","CAR"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02171\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2025-03-18","symbol":"02171","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742227200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-28","symbol":"02171","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"盤後","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-26","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-22","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692667800000,"name":null,"time":"","dateTimestamp":1692633600000,"actualEps":null},{"date":"2023-03-21","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679362200000,"name":null,"time":"","dateTimestamp":1679328000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02171\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02171\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1738857600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02171\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02171","date":"2025-05-02","current":-10.304543,"percent":0.141956,"low":-15.575744,"twenty":-9.374966,"median":-4.9885,"eighty":-2.587993,"high":-0.95958,"avg":-5.762553,"sd":3.591483,"marketCap":8773311140},"quantilePoints":[{"date":"2021-06-18","current":-13.296641,"twenty":-14.480215,"median":-14.415234,"eighty":-13.744078,"marketCap":17020400880},{"date":"2021-06-25","current":-14.103316,"twenty":-14.433431,"median":-14.120327,"eighty":-13.139055,"marketCap":18041624932},{"date":"2021-07-02","current":-13.483801,"twenty":-14.359655,"median":-13.987785,"eighty":-13.334073,"marketCap":17218972223},{"date":"2021-07-09","current":-14.564659,"twenty":-14.401025,"median":-13.915878,"eighty":-13.47657,"marketCap":18580604294},{"date":"2021-07-16","current":-13.475367,"twenty":-14.401025,"median":-14.081504,"eighty":-13.477054,"marketCap":17190604888},{"date":"2021-07-23","current":-13.409947,"twenty":-14.344062,"median":-13.826345,"eighty":-13.474883,"marketCap":17105502884},{"date":"2021-07-30","current":-12.788772,"twenty":-14.317545,"median":-13.553323,"eighty":-13.086527,"marketCap":16367952179},{"date":"2021-08-06","current":-11.842141,"twenty":-14.198244,"median":-13.484784,"eighty":-12.837817,"marketCap":15119789448},{"date":"2021-08-13","current":-15.575744,"twenty":-14.344062,"median":-13.505234,"eighty":-12.971066,"marketCap":19913869029},{"date":"2021-08-20","current":-13.617443,"twenty":-14.404773,"median":-13.617443,"eighty":-13.043173,"marketCap":17360808897},{"date":"2021-08-27","current":-3.504357,"twenty":-14.35918,"median":-13.505234,"eighty":-12.464271,"marketCap":20736521738},{"date":"2021-09-03","current":-4.6578,"twenty":-14.344062,"median":-13.483801,"eighty":-10.967699,"marketCap":27573049425},{"date":"2021-09-10","current":-4.110528,"twenty":-14.328504,"median":-13.442355,"eighty":-4.263773,"marketCap":24395907928},{"date":"2021-09-17","current":-4.50623,"twenty":-14.257307,"median":-13.296641,"eighty":-4.151025,"marketCap":26665294712},{"date":"2021-09-24","current":-4.556854,"twenty":-14.213471,"median":-13.240145,"eighty":-4.151247,"marketCap":26977335394},{"date":"2021-09-30","current":-5.205472,"twenty":-14.152565,"median":-13.033998,"eighty":-4.238734,"marketCap":30920394932},{"date":"2021-10-08","current":-4.274413,"twenty":-14.1254,"median":-12.746107,"eighty":-4.267672,"marketCap":25388764646},{"date":"2021-10-15","current":-4.004217,"twenty":-14.110956,"median":-12.40317,"eighty":-4.217063,"marketCap":23800193897},{"date":"2021-10-22","current":-4.042014,"twenty":-14.077142,"median":-11.842141,"eighty":-4.146115,"marketCap":24197336584},{"date":"2021-10-29","current":-3.995029,"twenty":-13.988568,"median":-7.719133,"eighty":-4.043027,"marketCap":23856928566},{"date":"2021-11-05","current":-3.490492,"twenty":-13.925987,"median":-4.848164,"eighty":-3.978881,"marketCap":20878358412},{"date":"2021-11-12","current":-4.109048,"twenty":-13.862158,"median":-4.772452,"eighty":-3.912909,"marketCap":24679581276},{"date":"2021-11-19","current":-4.398655,"twenty":-13.789344,"median":-4.652795,"eighty":-3.938397,"marketCap":26381621364},{"date":"2021-11-26","current":-3.881872,"twenty":-13.676336,"median":-4.461584,"eighty":-3.912909,"marketCap":23289581870},{"date":"2021-12-03","current":-3.780317,"twenty":-13.60454,"median":-4.407722,"eighty":-3.88002,"marketCap":22722235174},{"date":"2021-12-10","current":-3.872814,"twenty":-13.544799,"median":-4.373965,"eighty":-3.86241,"marketCap":23317949205},{"date":"2021-12-17","current":-3.625614,"twenty":-13.504139,"median":-4.27644,"eighty":-3.842315,"marketCap":21814480461},{"date":"2021-12-24","current":-2.910912,"twenty":-13.490775,"median":-4.265022,"eighty":-3.812246,"marketCap":17531012906},{"date":"2021-12-31","current":-2.585862,"twenty":-13.484391,"median":-4.247891,"eighty":-3.79337,"marketCap":15607269865},{"date":"2022-01-07","current":-2.232317,"twenty":-2.553006,"median":-2.430006,"eighty":-2.271168,"marketCap":13422252083},{"date":"2022-01-14","current":-2.293395,"twenty":-2.516293,"median":-2.440198,"eighty":-2.284514,"marketCap":13819528044},{"date":"2022-01-21","current":-1.973359,"twenty":-2.503055,"median":-2.379192,"eighty":-2.244424,"marketCap":11918278806},{"date":"2022-01-28","current":-1.567653,"twenty":-2.497826,"median":-2.282294,"eighty":-1.912458,"marketCap":9443817111},{"date":"2022-02-04","current":-1.597023,"twenty":-2.495835,"median":-2.271161,"eighty":-1.7445,"marketCap":9616028284},{"date":"2022-02-11","current":-1.527944,"twenty":-2.450389,"median":-2.232317,"eighty":-1.597023,"marketCap":9218671744},{"date":"2022-02-18","current":-1.640317,"twenty":-2.430006,"median":-1.957226,"eighty":-1.567653,"marketCap":9945266561},{"date":"2022-02-25","current":-1.752093,"twenty":-2.403518,"median":-1.752093,"eighty":-1.58606,"marketCap":10649155290},{"date":"2022-03-04","current":-1.721528,"twenty":-2.379192,"median":-1.802303,"eighty":-1.597023,"marketCap":10467392744},{"date":"2022-03-11","current":-1.27859,"twenty":-2.319774,"median":-1.7445,"eighty":-1.563041,"marketCap":7762463892},{"date":"2022-03-18","current":-1.343853,"twenty":-2.293395,"median":-1.710725,"eighty":-1.527944,"marketCap":8126151805},{"date":"2022-03-25","current":-1.48424,"twenty":-2.271193,"median":-1.66812,"eighty":-1.45262,"marketCap":8660318427},{"date":"2022-04-01","current":-1.382568,"twenty":-2.27113,"median":-1.625557,"eighty":-1.446309,"marketCap":8076671724},{"date":"2022-04-08","current":-1.446292,"twenty":-2.256223,"median":-1.603004,"eighty":-1.430534,"marketCap":8452595796},{"date":"2022-04-14","current":-1.315924,"twenty":-2.240389,"median":-1.599031,"eighty":-1.412577,"marketCap":7677964375},{"date":"2022-04-22","current":-1.166567,"twenty":-2.204172,"median":-1.58853,"eighty":-1.380244,"marketCap":6800808208},{"date":"2022-04-29","current":-1.03074,"twenty":-2.086516,"median":-1.563041,"eighty":-1.344275,"marketCap":5912260402},{"date":"2022-05-06","current":-1.048279,"twenty":-1.966906,"median":-1.532481,"eighty":-1.31332,"marketCap":5962912284},{"date":"2022-05-13","current":-1.095949,"twenty":-1.941092,"median":-1.527944,"eighty":-1.237924,"marketCap":6122531351},{"date":"2022-05-20","current":-1.1311,"twenty":-1.913082,"median":-1.491391,"eighty":-1.121103,"marketCap":6407565399},{"date":"2022-05-27","current":-1.122011,"twenty":-1.869508,"median":-1.469686,"eighty":-1.116891,"marketCap":6350558589},{"date":"2022-06-02","current":-1.110067,"twenty":-1.859596,"median":-1.45262,"eighty":-1.107798,"marketCap":6316675923},{"date":"2022-06-10","current":-1.242652,"twenty":-1.832277,"median":-1.441,"eighty":-1.109672,"marketCap":7023596333},{"date":"2022-06-17","current":-1.231899,"twenty":-1.788045,"median":-1.419625,"eighty":-1.110242,"marketCap":6955184681},{"date":"2022-06-24","current":-1.63937,"twenty":-1.757382,"median":-1.412127,"eighty":-1.11557,"marketCap":9292582811},{"date":"2022-06-30","current":-1.473408,"twenty":-1.747537,"median":-1.426443,"eighty":-1.117703,"marketCap":8337460134},{"date":"2022-07-08","current":-1.759827,"twenty":-1.772247,"median":-1.446292,"eighty":-1.11996,"marketCap":9968454388},{"date":"2022-07-15","current":-1.593377,"twenty":-1.768784,"median":-1.453067,"eighty":-1.121648,"marketCap":8941954508},{"date":"2022-07-22","current":-1.624828,"twenty":-1.763117,"median":-1.473408,"eighty":-1.12261,"marketCap":9124443376},{"date":"2022-07-29","current":-1.519392,"twenty":-1.755187,"median":-1.491391,"eighty":-1.127864,"marketCap":8542760110},{"date":"2022-08-05","current":-1.607124,"twenty":-1.747537,"median":-1.48424,"eighty":-1.145835,"marketCap":9013017933},{"date":"2022-08-12","current":-1.820283,"twenty":-1.755187,"median":-1.502802,"eighty":-1.160425,"marketCap":10222359580},{"date":"2022-08-19","current":-1.863313,"twenty":-1.782747,"median":-1.509519,"eighty":-1.165381,"marketCap":10359266181},{"date":"2022-08-26","current":-14.08994,"twenty":-1.828619,"median":-1.528134,"eighty":-1.181468,"marketCap":11694105546},{"date":"2022-09-02","current":-12.116182,"twenty":-1.859596,"median":-1.541739,"eighty":-1.20133,"marketCap":10019857778},{"date":"2022-09-09","current":-11.151252,"twenty":-1.91395,"median":-1.55979,"eighty":-1.211188,"marketCap":9186771653},{"date":"2022-09-16","current":-9.857086,"twenty":-1.984158,"median":-1.568909,"eighty":-1.216087,"marketCap":8045557783},{"date":"2022-09-23","current":-7.883202,"twenty":-2.263676,"median":-1.576689,"eighty":-1.224656,"marketCap":6310912701},{"date":"2022-09-30","current":-7.911041,"twenty":-2.355425,"median":-1.58489,"eighty":-1.231568,"marketCap":6345297469},{"date":"2022-10-07","current":-8.011101,"twenty":-2.446312,"median":-1.58858,"eighty":-1.233104,"marketCap":6425184307},{"date":"2022-10-14","current":-7.938783,"twenty":-2.526166,"median":-1.597023,"eighty":-1.238099,"marketCap":6299647847},{"date":"2022-10-21","current":-9.832614,"twenty":-6.942728,"median":-1.601309,"eighty":-1.239569,"marketCap":7749023348},{"date":"2022-10-28","current":-9.370789,"twenty":-7.773405,"median":-1.60443,"eighty":-1.244895,"marketCap":7372413965},{"date":"2022-11-04","current":-10.185604,"twenty":-7.996637,"median":-1.606458,"eighty":-1.25517,"marketCap":8091443115},{"date":"2022-11-11","current":-9.611502,"twenty":-8.36331,"median":-1.624828,"eighty":-1.264016,"marketCap":7703419045},{"date":"2022-11-18","current":-10.759022,"twenty":-8.806878,"median":-1.639844,"eighty":-1.279234,"marketCap":8593591912},{"date":"2022-11-25","current":-9.37601,"twenty":-9.141589,"median":-1.667958,"eighty":-1.287983,"marketCap":7429519701},{"date":"2022-12-02","current":-9.827805,"twenty":-9.368924,"median":-1.689407,"eighty":-1.31332,"marketCap":7921924171},{"date":"2022-12-09","current":-11.242992,"twenty":-9.562447,"median":-1.703343,"eighty":-1.32151,"marketCap":9146845972},{"date":"2022-12-16","current":-10.648692,"twenty":-9.641357,"median":-1.733014,"eighty":-1.343923,"marketCap":8643139811},{"date":"2022-12-23","current":-10.024984,"twenty":-9.741505,"median":-1.759827,"eighty":-1.344238,"marketCap":8139433650},{"date":"2022-12-30","current":-10.434012,"twenty":-9.817483,"median":-1.768967,"eighty":-1.344348,"marketCap":8574452607},{"date":"2023-01-06","current":-10.966641,"twenty":-9.842403,"median":-1.7838,"eighty":-1.348482,"marketCap":9104741856},{"date":"2023-01-13","current":-13.467972,"twenty":-9.98818,"median":-1.822183,"eighty":-1.35497,"marketCap":11395242952},{"date":"2023-01-20","current":-13.557236,"twenty":-10.173418,"median":-1.8366,"eighty":-1.365012,"marketCap":11372337941},{"date":"2023-01-27","current":-13.820637,"twenty":-10.199052,"median":-1.842332,"eighty":-1.370037,"marketCap":11595661798},{"date":"2023-02-03","current":-13.459803,"twenty":-10.378203,"median":-1.863313,"eighty":-1.370767,"marketCap":11351397072},{"date":"2023-02-10","current":-12.297733,"twenty":-10.466354,"median":-1.893269,"eighty":-1.373224,"marketCap":10309038714},{"date":"2023-02-17","current":-11.24262,"twenty":-10.626066,"median":-1.941092,"eighty":-1.378695,"marketCap":9335407279},{"date":"2023-02-24","current":-11.758835,"twenty":-10.767474,"median":-2.076656,"eighty":-1.382568,"marketCap":9644678441},{"date":"2023-03-03","current":-11.697374,"twenty":-10.840142,"median":-2.252496,"eighty":-1.394713,"marketCap":9656132928},{"date":"2023-03-10","current":-9.995937,"twenty":-10.174886,"median":-10.10778,"eighty":-10.040674,"marketCap":8190698973},{"date":"2023-03-17","current":-10.038612,"twenty":-11.309337,"median":-4.129297,"eighty":-1.557839,"marketCap":8305254204},{"date":"2023-03-24","current":-7.238043,"twenty":-11.300534,"median":-4.15097,"eighty":-1.563963,"marketCap":7434634452},{"date":"2023-03-31","current":-7.136417,"twenty":-11.285782,"median":-4.185168,"eighty":-1.568155,"marketCap":7274257130},{"date":"2023-04-06","current":-7.48964,"twenty":-11.272911,"median":-4.209273,"eighty":-1.569663,"marketCap":7629378344},{"date":"2023-04-14","current":-8.347684,"twenty":-11.261549,"median":-4.247213,"eighty":-1.570497,"marketCap":8511827184},{"date":"2023-04-21","current":-7.227891,"twenty":-11.248529,"median":-4.265022,"eighty":-1.574301,"marketCap":7366224602},{"date":"2023-04-28","current":-6.965007,"twenty":-11.242769,"median":-4.27644,"eighty":-1.577657,"marketCap":7045455879},{"date":"2023-05-05","current":-6.998831,"twenty":-11.223942,"median":-4.349275,"eighty":-1.58047,"marketCap":7091279982},{"date":"2023-05-12","current":-6.648882,"twenty":-11.178055,"median":-4.407495,"eighty":-1.584657,"marketCap":6690319078},{"date":"2023-05-19","current":-6.503974,"twenty":-11.148692,"median":-4.416938,"eighty":-1.5861,"marketCap":6452481216},{"date":"2023-05-25","current":-6.275646,"twenty":-11.143926,"median":-4.556854,"eighty":-1.587127,"marketCap":6200341630},{"date":"2023-06-02","current":-6.296999,"twenty":-11.114578,"median":-4.7039,"eighty":-1.591475,"marketCap":6200341630},{"date":"2023-06-09","current":-6.085036,"twenty":-11.002943,"median":-4.805724,"eighty":-1.594106,"marketCap":5982986890},{"date":"2023-06-16","current":-6.396517,"twenty":-10.96387,"median":-5.172616,"eighty":-1.59766,"marketCap":6259124746},{"date":"2023-06-23","current":-5.864103,"twenty":-10.952784,"median":-5.906495,"eighty":-1.60021,"marketCap":5706849033},{"date":"2023-06-30","current":-5.780429,"twenty":-10.933196,"median":-5.948886,"eighty":-1.601039,"marketCap":5574532977},{"date":"2023-07-07","current":-6.060693,"twenty":-10.906132,"median":-5.977284,"eighty":-1.601578,"marketCap":5833412218},{"date":"2023-07-14","current":-6.02436,"twenty":-10.889225,"median":-5.979717,"eighty":-1.602524,"marketCap":5879807825},{"date":"2023-07-21","current":-6.194623,"twenty":-10.840142,"median":-5.977284,"eighty":-1.60443,"marketCap":6017885504},{"date":"2023-07-28","current":-6.722973,"twenty":-10.819432,"median":-5.998155,"eighty":-1.604617,"marketCap":6524170327},{"date":"2023-08-04","current":-6.617116,"twenty":-10.804403,"median":-6.017966,"eighty":-1.605792,"marketCap":6432118541},{"date":"2023-08-10","current":-6.095496,"twenty":-10.792752,"median":-6.02436,"eighty":-1.606591,"marketCap":5891626475},{"date":"2023-08-18","current":-5.689786,"twenty":-10.774478,"median":-6.017966,"eighty":-1.609327,"marketCap":5460110864},{"date":"2023-08-25","current":-5.594472,"twenty":-10.762403,"median":-5.998155,"eighty":-1.619215,"marketCap":5540660445},{"date":"2023-09-01","current":-5.345867,"twenty":-10.753062,"median":-5.981578,"eighty":-1.628804,"marketCap":5316428769},{"date":"2023-09-08","current":-5.280752,"twenty":-10.708668,"median":-5.97485,"eighty":-1.636204,"marketCap":5189847132},{"date":"2023-09-15","current":-5.170409,"twenty":-10.661904,"median":-5.926032,"eighty":-1.639938,"marketCap":5120802603},{"date":"2023-09-22","current":-5.368163,"twenty":-10.635116,"median":-5.914502,"eighty":-1.646947,"marketCap":5293413926},{"date":"2023-09-29","current":-4.858025,"twenty":-10.624505,"median":-5.883829,"eighty":-1.661322,"marketCap":4798594798},{"date":"2023-10-06","current":-4.848749,"twenty":-10.61454,"median":-5.773557,"eighty":-1.668023,"marketCap":4787139493},{"date":"2023-10-13","current":-5.562225,"twenty":-10.564028,"median":-5.739914,"eighty":-1.675856,"marketCap":5483346078},{"date":"2023-10-20","current":-5.407133,"twenty":-10.491544,"median":-5.685854,"eighty":-1.689017,"marketCap":5322240422},{"date":"2023-10-27","current":-5.848058,"twenty":-10.464228,"median":-5.638197,"eighty":-1.692848,"marketCap":5753773430},{"date":"2023-11-03","current":-6.149851,"twenty":-10.451382,"median":-5.711436,"eighty":-1.699726,"marketCap":6066766557},{"date":"2023-11-10","current":-6.384576,"twenty":-10.4304,"median":-5.764995,"eighty":-1.706296,"marketCap":6297004377},{"date":"2023-11-17","current":-6.639835,"twenty":-10.408468,"median":-5.848058,"eighty":-1.718791,"marketCap":6607825434},{"date":"2023-11-24","current":-6.493833,"twenty":-10.378473,"median":-5.907382,"eighty":-1.726122,"marketCap":6515730306},{"date":"2023-12-01","current":-5.273334,"twenty":-10.37221,"median":-5.903555,"eighty":-1.746019,"marketCap":5313056131},{"date":"2023-12-08","current":-5.174269,"twenty":-10.330292,"median":-5.814243,"eighty":-1.75364,"marketCap":5192174031},{"date":"2023-12-15","current":-3.798534,"twenty":-10.253372,"median":-5.763304,"eighty":-1.761472,"marketCap":3833689473},{"date":"2023-12-22","current":-3.418682,"twenty":-10.23016,"median":-5.700611,"eighty":-1.768418,"marketCap":3448018009},{"date":"2023-12-29","current":-3.690081,"twenty":-10.222257,"median":-5.681922,"eighty":-1.769516,"marketCap":3741588825},{"date":"2024-01-05","current":-3.436204,"twenty":-10.217047,"median":-5.591562,"eighty":-1.775076,"marketCap":3459596526},{"date":"2024-01-12","current":-3.457234,"twenty":-10.205563,"median":-5.536622,"eighty":-1.784852,"marketCap":3482622127},{"date":"2024-01-19","current":-3.16443,"twenty":-10.190983,"median":-5.505597,"eighty":-1.807794,"marketCap":3183289316},{"date":"2024-01-26","current":-2.65403,"twenty":-10.173418,"median":-5.476058,"eighty":-1.821423,"marketCap":2659456897},{"date":"2024-02-02","current":-2.249035,"twenty":-10.089285,"median":-5.426105,"eighty":-1.824513,"marketCap":2250760075},{"date":"2024-02-09","current":-2.587166,"twenty":-10.030435,"median":-5.409235,"eighty":-1.829896,"marketCap":2601901672},{"date":"2024-02-16","current":-2.809787,"twenty":-10.022591,"median":-5.397864,"eighty":-1.834109,"marketCap":2826402038},{"date":"2024-02-23","current":-3.595568,"twenty":-10.01212,"median":-5.379088,"eighty":-1.841383,"marketCap":3597762268},{"date":"2024-03-01","current":-3.806058,"twenty":-10.006005,"median":-5.366225,"eighty":-1.846553,"marketCap":3810756223},{"date":"2024-03-08","current":-3.517028,"twenty":-9.991673,"median":-5.353274,"eighty":-1.858357,"marketCap":3522934756},{"date":"2024-03-15","current":-3.669692,"twenty":-9.971476,"median":-5.345687,"eighty":-1.864552,"marketCap":3672601918},{"date":"2024-03-22","current":-3.454281,"twenty":-9.939836,"median":-5.324793,"eighty":-1.870298,"marketCap":3453857604},{"date":"2024-03-28","current":-4.293587,"twenty":-9.863568,"median":-5.283345,"eighty":-1.873457,"marketCap":3476883321},{"date":"2024-04-05","current":-4.296416,"twenty":-9.859679,"median":-5.278537,"eighty":-1.897232,"marketCap":3476883321},{"date":"2024-04-12","current":-4.06649,"twenty":-9.842403,"median":-5.265351,"eighty":-1.914383,"marketCap":3292683193},{"date":"2024-04-19","current":-3.201894,"twenty":-9.830267,"median":-5.246113,"eighty":-1.930756,"marketCap":2590397617},{"date":"2024-04-26","current":-3.882637,"twenty":-9.828164,"median":-5.227283,"eighty":-1.960452,"marketCap":3137259336},{"date":"2024-05-03","current":-4.412872,"twenty":-9.822644,"median":-5.190892,"eighty":-1.980559,"marketCap":3563235833},{"date":"2024-05-10","current":-4.388196,"twenty":-9.799273,"median":-5.172187,"eighty":-2.059596,"marketCap":3551722955},{"date":"2024-05-17","current":-4.665305,"twenty":-9.769071,"median":-5.13976,"eighty":-2.176027,"marketCap":3770467643},{"date":"2024-05-24","current":-4.768789,"twenty":-9.741505,"median":-5.06514,"eighty":-2.235661,"marketCap":3845301352},{"date":"2024-05-31","current":-4.899442,"twenty":-9.731744,"median":-5.028419,"eighty":-2.249727,"marketCap":3954673696},{"date":"2024-06-07","current":-4.27374,"twenty":-9.695026,"median":-5.010041,"eighty":-2.252748,"marketCap":3445348655},{"date":"2024-06-14","current":-4.391089,"twenty":-9.670514,"median":-4.9885,"eighty":-2.253757,"marketCap":3536708036},{"date":"2024-06-21","current":-3.957414,"twenty":-9.669207,"median":-4.858025,"eighty":-2.27113,"marketCap":3180740669},{"date":"2024-06-28","current":-3.416267,"twenty":-9.656329,"median":-4.848456,"eighty":-2.271193,"marketCap":2744658792},{"date":"2024-07-05","current":-3.116409,"twenty":-9.644569,"median":-4.823842,"eighty":-2.288955,"marketCap":2503206857},{"date":"2024-07-12","current":-3.048649,"twenty":-9.640541,"median":-4.794904,"eighty":-2.314498,"marketCap":2452377267},{"date":"2024-07-19","current":-3.241813,"twenty":-9.626631,"median":-4.759394,"eighty":-2.33858,"marketCap":2607809629},{"date":"2024-07-26","current":-2.96601,"twenty":-9.621662,"median":-4.747373,"eighty":-2.37201,"marketCap":2394809726},{"date":"2024-08-02","current":-2.789389,"twenty":-9.613456,"median":-4.667015,"eighty":-2.39703,"marketCap":2250890872},{"date":"2024-08-09","current":-2.772124,"twenty":-9.574791,"median":-4.652795,"eighty":-2.403112,"marketCap":2251867265},{"date":"2024-08-16","current":-2.862478,"twenty":-9.552947,"median":-4.531542,"eighty":-2.424708,"marketCap":2326167454},{"date":"2024-08-23","current":-2.5913,"twenty":-9.491495,"median":-4.424353,"eighty":-2.446312,"marketCap":2114697685},{"date":"2024-08-30","current":-2.433132,"twenty":-9.396193,"median":-4.410397,"eighty":-2.432506,"marketCap":1857504723},{"date":"2024-09-06","current":-2.012915,"twenty":-9.371833,"median":-4.407267,"eighty":-2.384786,"marketCap":1537442371},{"date":"2024-09-13","current":-2.34081,"twenty":-9.36333,"median":-4.390474,"eighty":-2.314498,"marketCap":1783204534},{"date":"2024-09-20","current":-2.282109,"twenty":-9.359966,"median":-4.387939,"eighty":-2.289347,"marketCap":1748912139},{"date":"2024-09-27","current":-3.172887,"twenty":-9.315256,"median":-4.349275,"eighty":-2.289347,"marketCap":2446190836},{"date":"2024-10-04","current":-3.522485,"twenty":-9.280278,"median":-4.336648,"eighty":-2.294847,"marketCap":2703383797},{"date":"2024-10-10","current":-3.419324,"twenty":-9.25963,"median":-4.323569,"eighty":-2.300216,"marketCap":2607219971},{"date":"2024-10-18","current":-2.901761,"twenty":-9.198146,"median":-4.295001,"eighty":-2.314342,"marketCap":2201042544},{"date":"2024-10-25","current":-3.003259,"twenty":-9.141589,"median":-4.274413,"eighty":-2.323828,"marketCap":2277886922},{"date":"2024-11-01","current":-3.464077,"twenty":-9.136448,"median":-4.265022,"eighty":-2.340197,"marketCap":2629175507},{"date":"2024-11-08","current":-5.509053,"twenty":-9.10619,"median":-4.260606,"eighty":-2.341304,"marketCap":4149596417},{"date":"2024-11-15","current":-4.478987,"twenty":-8.973808,"median":-4.274076,"eighty":-2.350464,"marketCap":3348219331},{"date":"2024-11-22","current":-5.156949,"twenty":-8.806878,"median":-4.293587,"eighty":-2.380591,"marketCap":3853196673},{"date":"2024-11-29","current":-4.888422,"twenty":-8.7186,"median":-4.321083,"eighty":-2.389246,"marketCap":3650107959},{"date":"2024-12-06","current":-5.106278,"twenty":-8.679179,"median":-4.336648,"eighty":-2.401895,"marketCap":3803796715},{"date":"2024-12-13","current":-7.146685,"twenty":-8.563165,"median":-4.35718,"eighty":-2.408816,"marketCap":5313239857},{"date":"2024-12-20","current":-6.244103,"twenty":-8.379524,"median":-4.388196,"eighty":-2.430631,"marketCap":4621640454},{"date":"2024-12-27","current":-6.226686,"twenty":-8.355644,"median":-4.390474,"eighty":-2.432507,"marketCap":4605173801},{"date":"2025-01-03","current":-7.139968,"twenty":-8.299043,"median":-4.402961,"eighty":-2.443486,"marketCap":5285795436},{"date":"2025-01-10","current":-6.88431,"twenty":-8.223849,"median":-4.407922,"eighty":-2.477657,"marketCap":5077217838},{"date":"2025-01-17","current":-7.629845,"twenty":-8.182771,"median":-4.420646,"eighty":-2.498821,"marketCap":5631595137},{"date":"2025-01-24","current":-7.597114,"twenty":-8.182771,"median":-4.478987,"eighty":-2.502283,"marketCap":5642572906},{"date":"2025-01-28","current":-7.410475,"twenty":-8.174393,"median":-4.50623,"eighty":-2.503264,"marketCap":5532795223},{"date":"2025-02-07","current":-6.905522,"twenty":-8.129174,"median":-4.573822,"eighty":-2.50642,"marketCap":5126617796},{"date":"2025-02-14","current":-7.544999,"twenty":-8.122982,"median":-4.652795,"eighty":-2.520444,"marketCap":5598661833},{"date":"2025-02-21","current":-9.434583,"twenty":-8.198204,"median":-4.667015,"eighty":-2.522105,"marketCap":7025771712},{"date":"2025-02-28","current":-11.802643,"twenty":-8.387484,"median":-4.740857,"eighty":-2.531102,"marketCap":8760259103},{"date":"2025-03-07","current":-11.8291,"twenty":-8.82761,"median":-4.749818,"eighty":-2.53167,"marketCap":8815147944},{"date":"2025-03-14","current":-9.365593,"twenty":-9.14248,"median":-4.791751,"eighty":-2.532953,"marketCap":6981860638},{"date":"2025-03-21","current":-8.003288,"twenty":-9.184856,"median":-4.800314,"eighty":-2.534267,"marketCap":6850127419},{"date":"2025-03-28","current":-10.15866,"twenty":-9.193009,"median":-4.826251,"eighty":-2.537422,"marketCap":8677346303},{"date":"2025-04-03","current":-9.469219,"twenty":-9.300685,"median":-4.848749,"eighty":-2.539639,"marketCap":8072461580},{"date":"2025-04-11","current":-7.909154,"twenty":-9.274441,"median":-4.873223,"eighty":-2.576728,"marketCap":6697723572},{"date":"2025-04-17","current":-8.252995,"twenty":-9.235847,"median":-4.894545,"eighty":-2.58622,"marketCap":7005664886},{"date":"2025-04-25","current":-9.96754,"twenty":-9.360466,"median":-4.944659,"eighty":-2.586741,"marketCap":8468386126},{"date":"2025-05-02","current":-10.304543,"twenty":-9.374966,"median":-4.9885,"eighty":-2.587993,"marketCap":8773311140}],"updateTime":1746255708763}}}